Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Journal of Experimental Medicine|January 10, 2002
Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope proteinStefania Crotta, Annalisa Stilla, Andreas Wack, et al.
Vaccine|November 17, 2012
The role of non-viral antigens in the cotton rat model of respiratory syncytial virus vaccine-enhanced diseaseChristine A Shaw, Jean-Rene Galarneau, Kathryn E Bowenkamp, et al.
Science Translational Medicine|December 26, 2014
mTOR inhibition improves immune function in the elderlyJoan B Mannick, Giuseppe Del Giudice, Maria Lattanzi, et al.
Human Vaccines & Immunotherapeutics|May 30, 2015
A new TLR2 agonist promotes cross-presentation by mouse and human antigen presenting cellsMelissa Santone, Susanna Aprea, Tom Y H Wu, et al.
Scientific Reports|July 22, 2016
Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccinesCecilia Buonsanti, Cristiana Balocchi, Carole Harfouche, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2011
A point mutation in the amino terminus of TLR7 abolishes signaling without affecting ligand bindingCarlo Iavarone, Katrin Ramsauer, Andriy V Kubarenko, et al.
Antiviral Chemistry & Chemotherapy|December 13, 2012
Topical SMIP-7.7, a toll-like receptor 7 agonist, protects against genital herpes simplex virus type-2 disease in the guinea pig model of genital herpesDavid I Bernstein, Rhonda D Cardin, Fernando J Bravo, et al.
Nature|April 15, 2026
mRNA vaccines engage unconventional pathways in CD8<sup>+</sup> T cell primingSuin Jo, Lijin Li, Chandrani Thakur, et al.
Pageof 3